Christoph Brackmann
Vermögen: 3 Mio $ am 30.06.2026
Vermögen: 3 Mio $ am 30.06.2026
Mr. Christoph Brackmann is a Chief Financial Officer at NovoCure Ltd. Mr. Brackmann was previously employed as a Senior Vice President-Finance by Moderna, Inc. and a Global Head-Investor Relations by Shire Plc.
He received his undergraduate degree from the University of Mannheim and an MBA from SDA Bocconi School of Management.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NOVOCURE LTD. 0.16% | 06.04.2026 | 188’144 ( 0.16% ) | 3 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVOCURE LIMITED | Finanzdirektor/CFO | 01.01.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | - |
| SHIRE | Public Communications Contact | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
University of Mannheim
University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
SDA Bocconi School of Management
SDA Bocconi School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen